When pharmacy-controlled portal pricing breaks — go pass-through

A PharmacyLive portal sets your cost through whatever that deploying pharmacy configured for your account inside their branded instance. PharmacyLive is sold to compounding pharmacies — clinics do not buy it directly — so the per-vial number you see is pharmacy-controlled, varies by deployment, and does not compare across compounders when each pharmacy runs its own white-label login. That can produce workable rates when one compounder covers your formulary. The cost is visibility and reach: you do not see landed cost across every partner at the moment you are quoting a patient, and adding a second compounder means a second portal with its own pricing rules.

A pass-through model inverts that at the clinic layer. With Fizy Health, the resolved 503A landed cost appears on each catalog and cart line before you check out, and the platform's margin is a disclosed facilitation fee at payment rather than an opaque per-vial markup buried inside pharmacy-set portal pricing. The drug cost is what the pharmacy charges; the platform fee is stated separately. For a clinic quoting cash-pay semaglutide or tirzepatide daily across multiple 503A partners, that means the price you quote and the price you pay are the same visible number network-wide — regardless of whether a given pharmacy runs PharmacyLive, LifeFile, or another portal on the fulfillment side.

Replace pharmacy-controlled portal pricing when opacity actively slows your business. Common signals: you delay quoting a new patient because you are checking rates in a compounder's PharmacyLive portal instead of your clinic cart; you cannot confidently set cash-pay prices because landed cost is not visible across every partner before checkout; you use two or more compounders and compare margin pharmacy-by-pharmacy in separate white-label logins; or your volume has shifted and you are not sure each pharmacy's portal pricing still reflects your current formulary mix.

Another signal is operational, not just financial: if paid orders get rejected after payment for SIG or licensure issues, the pricing question compounds with a validation gap. A pass-through platform like Fizy Health pairs visible per-vial cost with pre-submit cart validation, so the same workflow that shows your margin also catches the errors that cost you a refund cycle. If none of these signals apply — one compounder's PharmacyLive portal covers your formulary and refill day is clean — pharmacy-controlled pricing may still be the right fit. Replace it when the model, not the vendor, is the constraint.